CD82 expression was significantly decreased in tumour versus normal lung tissue (p < 0.001), while there was also a significant difference between tumour types as only 6% of the LUAD samples were found positive for CD82 expression compared to 22% of LUSC patient samples (p < 0.05) (Figure 4B). Here, CD82 is linked to neoplasm.